Clinical Trials Browser

Phase 2 × Craniopharyngioma × tocilizumab × Clear all

NCT05233397 2026-03-02

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2 Recruiting

Craniopharyngioma